Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Operating Leases (2024 - 2025)

Historic Operating Leases for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $17.4 million.

  • Pyxis Oncology's Operating Leases fell 856.54% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year decrease of 856.54%. This contributed to the annual value of $18.6 million for FY2024, which is N/A changed from last year.
  • Per Pyxis Oncology's latest filing, its Operating Leases stood at $17.4 million for Q3 2025, which was down 856.54% from $17.8 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Operating Leases high stood at $19.8 million for Q1 2024, and its period low was $17.4 million during Q3 2025.